DOT1L-HES6 fusion drives androgen independent growth in prostate cancer

অনুযায়ী Annala, Matti, Kivinummi, Kati, Leinonen, Katri, Tuominen, Joonas, Zhang, Wei, Visakorpi, Tapio, Nykter, Matti
প্রকাশিত 2014

The expression of AURKA is androgen regulated in castration-resistant prostate cancer

অনুযায়ী Kivinummi, Kati, Urbanucci, Alfonso, Leinonen, Katri, Tammela, Teuvo L. J., Annala, Matti, Isaacs, William B., Bova, G. Steven, Nykter, Matti, Visakorpi, Tapio
প্রকাশিত Sci Rep (2017)

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression

অনুযায়ী Latonen, Leena, Afyounian, Ebrahim, Jylhä, Antti, Nättinen, Janika, Aapola, Ulla, Annala, Matti, Kivinummi, Kati K., Tammela, Teuvo T. L., Beuerman, Roger W., Uusitalo, Hannu, Nykter, Matti, Visakorpi, Tapio
প্রকাশিত Nat Commun (2018)

Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer

অনুযায়ী Bova, G. Steven, Kallio, Heini M.L., Annala, Matti, Kivinummi, Kati, Högnäs, Gunilla, Häyrynen, Sergei, Rantapero, Tommi, Kivinen, Virpi, Isaacs, William B., Tolonen, Teemu, Nykter, Matti, Visakorpi, Tapio
প্রকাশিত Cold Spring Harb Mol Case Stud (2016)

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases

অনুযায়ী Kallio, Heini M. L., Hieta, Reija, Latonen, Leena, Brofeldt, Anniina, Annala, Matti, Kivinummi, Kati, Tammela, Teuvo L., Nykter, Matti, Isaacs, William B., Lilja, Hans G., Bova, G. Steven, Visakorpi, Tapio
প্রকাশিত Br J Cancer (2018)

CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations

অনুযায়ী Khanna, Anchit, Rane, Jayant K., Kivinummi, Kati K., Urbanucci, Alfonso, Helenius, Merja A., Tolonen, Teemu T., Saramäki, Outi R., Latonen, Leena, Manni, Visa, Pimanda, John E., Maitland, Norman J., Westermarck, Jukka, Visakorpi, Tapio
প্রকাশিত Oncotarget (2015)

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer

অনুযায়ী Annala, Matti, Kivinummi, Kati, Tuominen, Joonas, Karakurt, Serdar, Granberg, Kirsi, Latonen, Leena, Ylipää, Antti, Sjöblom, Liisa, Ruusuvuori, Pekka, Saramäki, Outi, Kaukoniemi, Kirsi M., Yli-Harja, Olli, Vessella, Robert L., Tammela, Teuvo L.J, Zhang, Wei, Visakorpi, Tapio, Nykter, Matti
প্রকাশিত Oncotarget (2015)

The Evolutionary History of Lethal Metastatic Prostate Cancer

অনুযায়ী Gundem, Gunes, Van Loo, Peter, Kremeyer, Barbara, Alexandrov, Ludmil B., Tubio, Jose M.C., Papaemmanuil, Elli, Brewer, Daniel S., Kallio, Heini M.L., Högnäs, Gunilla, Annala, Matti, Kivinummi, Kati, Goody, Victoria, Latimer, Calli, O’Meara, Sarah, Dawson, Kevin J., Isaacs, William, Emmert-Buck, Michael R, Nykter, Matti, Foster, Christopher, Kote-Jarai, Zsofia, Easton, Douglas, Whitaker, Hayley C., Neal, David E., Cooper, Colin S., Eeles, Rosalind A., Visakorpi, Tapio, Campbell, Peter J., McDermott, Ultan, Wedge, David C., Bova, G. Steven
প্রকাশিত Nature (2015)

Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer

অনুযায়ী Urbanucci, Alfonso, Barfeld, Stefan, Kytölä, Ville, Itkonen, Harri M., Coleman, Ilsa M., Vodák, Daniel, Sjöblom, Liisa, Sheng, Xia, Tolonen, Teemu, Minner, Sarah, Burdelski, Christoph, Kivinummi, Kati K., Kohvakka, Annika, Kregel, Steven, Takhar, Mandeep, Alshalalfa, Mohammed, Davicioni, Elai, Erho, Nicholas, Lloyd, Paul, Karnes, R. Jeffrey, Ross, Ashley E., Schaeffer, Edward M., Vander Griend, Donald J., Knapp, Stefan, Corey, Eva, Feng, Felix Y., Nelson, Peter S., Saatcioglu, Fahri, Knudsen, Karen E., Tammela, Teuvo L.J., Sauter, Guido, Schlomm, Thorsten, Nykter, Matti, Visakorpi, Tapio, Mills, Ian G.
প্রকাশিত Cell Rep (2017)